Restricted accessResearch articleFirst published online 2018-11
Approach to the Assessment and Management of Adult Patients With Atopic Dermatitis: A Consensus Document. Section I: Pathophysiology of Atopic Dermatitis and Implications for Systemic Therapy
Atopic dermatitis (AD) is a chronic, relapsing, and remitting inflammatory skin disease whose onset typically occurs early in life. AD pathophysiology includes genetic, immune, and environmental factors contributing to chronic inflammation. A rapidly evolving understanding of the pathogenesis of AD has led to the development of several treatment options for AD in adults, including topicals, phototherapy, and systemic therapies. Here, we provide a concise summary of AD pathophysiology with a focus on implications for systemic therapy.
EichenfieldLFTomWLChamlinSLet al. Guidelines of care for the management of atopic dermatitis Section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014;70(2):338-351.
EichenfieldLFHanifinJMLugerTAet al. Consensus conference on pediatric atopic dermatitis. J Am Acad Dermatol. 2003;49(6):1088-1095.
4.
KayJGawkrodgerDMortimerMet al. The prevalence of childhood atopic eczema in a general population. J Am Acad Dermatol. 1994;30(1):35-39.
5.
SilverbergJIHanifinJM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Invest Dermatol. 2013;132(5):1132-1138.
6.
EliasPMSchmuthM. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009;9(5):437-446.
7.
BrunnerPMLeungDGuttman-YasskyE. Immunologic, microbial, and epithelial interactions in atopic dermatitis. Ann Allergy Asthma Immunol. 2018;120(1):34-41.
8.
WynnTA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015;15(5):271-282.
9.
EberlGColonnaMDi SantoJPMcKenzieAN. Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology. Science. 2015;348(6237):aaa6566.
10.
PalmerCNIrvineADTerron-KwiatkowskiAet al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-446.
11.
SeidenariSGiustiG. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm Venereol. 1995;75(6):429-433.
12.
SimpsonELChalmersJRHanifinJMet al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134(4):818-823.
13.
HorimukaiKMoritaKNaritaMet al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):824-830.e6.
14.
KawasakiHNagaoKKuboAet al. Altered stratum corneum barrier and enhanced percutaneous immune responses in filaggrin-null mice. J Allergy Clin Immunol. 2012;129(6):1538-1546.e6.
15.
FallonPGSasakiTSandilandsAet al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet. 2009;41(5):602-608.
16.
JeongSKimHYoumJ-Ket al. Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol. 2008;128(8):1930-1939.
17.
ThyssenJPKezicS. Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis. J Allergy Clin Immunol. 2014;134(4):792-799.
18.
OyoshiMKLarsonRPZieglerSFGehaRS. Mechanical injury polarizes skin dendritic cells to elicit a TH2 response by inducing cutaneous thymic stromal lymphopoietin expression. J Allergy Clin Immunol. 2010;126(5):976-984.e1-5.
19.
OnoueAKabashimaKKobayashiMMoriTTokuraY. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin. Exp Dermatology. 2009;18(12):1036-1043.
20.
GittlerJKWangJFOrlowSJ. Bathing and associated treatments in atopic dermatitis. Am J Clin Dermatol. 2017;18(1):45-57.
21.
WerfelTAllamJ-PBiedermannTet al. Cellular and molecular immunologic mechanisms in patients with atopic dermatitis. J Allergy Clin Immunol. 2016;138(2):336-349.
22.
HönzkeSWallmeyerLOstrowskiAet al. Influence of Th2 cytokines on the cornified envelope, tight junction proteins, and β-defensins in filaggrin-deficient skin equivalents. J Invest Dermatol. 2016;136(3):631-639.
23.
SonkolyEMullerALauermaAIet al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411-417.
MollanazarNKSmithPKYosipovitchG. Mediators of chronic pruritus in atopic dermatitis: getting the itch out?Clin Rev Allergy Immunol. 2015;51(3):263-292.
26.
WilsonSRThéLBatiaLMet al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285-295.
27.
TominagaMOzawaSTengaraSOgawaHTakamoriK. Intraepidermal nerve fibers increase in dry skin of acetone-treated mice. J Dermatol Sci. 2007;48(2):103-111.
28.
OngPYOhtakeTBrandtCet al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Medicine. 2002;347(15):1151-1160.
29.
NakatsujiTChenTHNaralaSet al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017;9(378):pii:eaah4680.
30.
KongHOhJDemingCet al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850-859.
31.
KabashimaKOtsukaANomuraT. Linking air pollution to atopic dermatitis. Nat Immunol. 2017;18(1):5-6.
32.
KimK. Influences of environmental chemicals on atopic dermatitis. Toxicol Res. 2015;31(2):89-96.
SatoJDendaMChangSEliasPMFeingoldKR. Abrupt decreases in environmental humidity induce abnormalities in permeability barrier homeostasis. J Invest Dermatol. 2002;119(4):900-904.
35.
GoadNGawkrodgerDJ. Ambient humidity and the skin: the impact of air humidity in healthy and diseased states. J Eur Acad Dermatol Venereol. 2016;30(8):1285-1294.
36.
ChiangCEichenfieldLF. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. Pediatr Dermatol. 2009;26(3):273-278.
37.
CzarnowickiTEsakiHGonzalezJet al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)+ TH2/TH1 cell imbalance, whereas adults acquire CLA+ TH22/TC22 cell subsets. J Allergy Clin Immunol. 2015;136(4):941-951.e3.
38.
Suárez-FariñasMDhingraNGittlerJet al. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis. J Allergy Clin Immunol. 2013;132(2):361-370.
39.
MoyAPMuraliMKroshinskyDDuncanLMNazarianRM. Immunologic overlap of helper T-cell subtypes 17 and 22 in erythrodermic psoriasis and atopic dermatitis. JAMA Dermatol. 1970;151(7):753-760.
40.
KerschenlohrKDecardSPrzybillaBWollenbergA. Atopy patch test reactions show a rapid influx of inflammatory dendritic epidermal cells in patients with extrinsic atopic dermatitis and patients with intrinsic atopic dermatitis. J Allergy Clin Immunol. 2003;111(4):869-874.
41.
SaekiHKabashimaKTokuraYet al. Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study. Br J Dermatol. 2017;177(2):419-427.
42.
KhattriSBrunnerPMGarcetSet al. Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis. Exp Dermatol. 2017;26(1):28-35.
43.
RingJAlomarABieberTet al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045-1060.
44.
RingJAlomarABieberTet al. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol. 2012;26(9):1176-1193.
45.
SimpsonELBruin-WellerMFlohrCet al. When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council. J Am Acad Dermatol. 2017;77(4):623-633.
46.
BoguniewiczMAlexisAFBeckLAet al. Expert perspectives on management of moderate-to-severe atopic dermatitis: a multidisciplinary consensus addressing current and emerging therapies. J Allergy Clin Immunol. 2017;5(6):1519-1531.
47.
SchneiderLTillesSLioPet al. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013;131(2):295-299.e1-27.
48.
LyndeCWBourcierMGooderhamMet al. A treatment algorithm for moderate to severe atopic dermatitis in adults. J Cutan Med Surg. 2018;22(1):78-83.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
